MLN2480
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MLN2480, covering 2020-02-25 to 2020-08-10. Get the full timeline:
Most recent: Clinical Trial Update: Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma [Phase 1]